RNA-Binding Protein LIN28a Regulates New Myocyte Formation in the Heart Through Long Noncoding RNA-H19
Circulation · 24.01.2023 · 147 (4) · 324-337
DOI: 10.1161/circulationaha.122.059346 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 24.01.2023. Verfasst von Vagner Oliveira Carvalho Rigaud und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Metabolic Disease Research (V.0.C.R., R.C.H., J.K., C.Z., M.B., I.B., J.P., T.P., M.K.), Lewis Katz School of Medicine, Temple University,…. Hauptthemen laut MEDLINE: Myocardial Infarction, RNA, Long Noncoding, RNA-Binding Proteins. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, HHS | NIH | NHLBI | NHLBI Division of Intramural Research, American Heart Association.
Abstract (Originalsprache)
Background
Developmental cardiac tissue holds remarkable capacity to regenerate after injury and consists of regenerative mononuclear diploid cardiomyocytes. On maturation, mononuclear diploid cardiomyocytes become binucleated or polyploid and exit the cell cycle. Cardiomyocyte metabolism undergoes a profound shift that coincides with cessation of regeneration in the postnatal heart. However, whether reprogramming metabolism promotes persistence of regenerative mononuclear diploid cardiomyocytes enhancing cardiac function and repair after injury is unknown. Here, we identify a novel role for RNA-binding protein LIN28a, a master regulator of cellular metabolism in cardiac repair after injury.
Methods
LIN28a overexpression was tested using mouse transgenesis on postnatal cardiomyocyte numbers, cell cycle, and response to apical resection injury. With the use of neonatal and adult cell culture systems and adult and Mosaic Analysis with Double Markers myocardial injury models in mice, the effect of LIN28a overexpression on cardiomyocyte cell cycle and metabolism was tested. Last, isolated adult cardiomyocytes from LIN28a and wild-type mice 4 days after myocardial injury were used for RNA-immunoprecipitation sequencing.
Results
LIN28a was found to be active primarily during cardiac development and rapidly decreases after birth. LIN28a reintroduction at postnatal day (P) 1, P3, P5, and P7 decreased maturation-associated polyploidization, nucleation, and cell size, enhancing cardiomyocyte cell cycle activity in LIN28a transgenic pups compared with wild-type littermates. Moreover, LIN28a overexpression extended cardiomyocyte cell cycle activity beyond P7 concurrent with increased cardiac function 30 days after apical resection. In the adult heart, LIN28a overexpression attenuated cardiomyocyte apoptosis, enhanced cell cycle activity, cardiac function, and survival in mice 12 weeks after myocardial infarction compared with wild-type littermate controls. Instead, LIN28a small molecule inhibitor attenuated the proreparative effects of LIN28a on the heart. Neonatal rat ventricular myocytes overexpressing LIN28a mechanistically showed increased glycolysis, ATP production, and levels of metabolic enzymes compared with control. LIN28a immunoprecipitation followed by RNA-immunoprecipitation sequencing in cardiomyocytes isolated from LIN28a-overexpressing hearts after injury identified long noncoding RNA-H19 as its most significantly altered target. Ablation of long noncoding RNA-H19 blunted LIN28a-induced enhancement on cardiomyocyte metabolism and cell cycle activity.
Conclusions
Collectively, LIN28a reprograms cardiomyocyte metabolism and promotes persistence of mononuclear diploid cardiomyocytes in the injured heart, enhancing proreparative processes, thereby linking cardiomyocyte metabolism to regulation of ploidy/nucleation and repair in the heart.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Metabolic Disease Research (V.0.C.R., R.C.H., J.K., C.Z., M.B., I.B., J.P., T.P., M.K.), Lewis Katz School of Medicine, Temple University, Philadelphia, PA.
- Center for Cardiovascular Research (T.W., J.J., L.M.K., S.M., S.R.H.), Lewis Katz School of Medicine, Temple University, Philadelphia, PA.
- Department of Cardiovascular Sciences (M.K.), Lewis Katz School of Medicine, Temple University, Philadelphia, PA.
ORCID-Profile: Robert C Hoy, Michael Behanan, Steven R Houser, Mohsin Khan
Förderung
- NHLBI NIH HHS
- HHS | NIH | NHLBI | NHLBI Division of Intramural Research
- American Heart Association
Zitieren
APA
Rigaud, V. O. C., Hoy, R. C., Kurian, J., Zarka, C., Behanan, M., Brosious, I., Pennise, J., Patel, T., Wang, T., Johnson, J., Kraus, L. M., Mohsin, S., Houser, S. R., & Khan, M. (2023). RNA-Binding Protein LIN28a Regulates New Myocyte Formation in the Heart Through Long Noncoding RNA-H19. Circulation, 147(4), 324-337. https://doi.org/10.1161/circulationaha.122.059346
Vancouver
Rigaud VOC, Hoy RC, Kurian J, Zarka C, Behanan M, Brosious I, et al. RNA-Binding Protein LIN28a Regulates New Myocyte Formation in the Heart Through Long Noncoding RNA-H19. Circulation. 2023;147(4):324-337. doi:10.1161/circulationaha.122.059346
BibTeX
@article{Rigaud2023,
author = {Rigaud, Vagner Oliveira Carvalho and Hoy, Robert C and Kurian, Justin and Zarka, Clare and Behanan, Michael and Brosious, Isabella and Pennise, Jennifer and Patel, Tej and Wang, Tao and Johnson, Jaslyn and Kraus, Lindsay M and Mohsin, Sadia and Houser, Steven R and Khan, Mohsin},
title = {RNA-Binding Protein LIN28a Regulates New Myocyte Formation in the Heart Through Long Noncoding RNA-H19},
journal = {Circulation},
year = {2023},
volume = {147},
number = {4},
pages = {324--337},
doi = {10.1161/circulationaha.122.059346}
}
EUVIMED